Auna S.A.
Auna S.A. Class A Ordinary Shares represent ownership in Auna S.A., a healthcare services company focused on delivering integrated medical care across Latin America. Auna operates hospitals and clinics in Mexico, Peru, and Colombia, supported by a network that includes outpatient centers, diagnostic services, and specialty care facilities. The company also offers prepaid healthcare plans in Peru, dental and vision insurance in Mexico, and oncology-related plans, while complementing its services with medicine sales. Through these businesses, Auna serves individuals and families seeking coordinated access to medical treatment, preventive care, and specialized health coverage. Headquartered in Luxembourg, Auna plays a role in the region’s healthcare market by combining provider services with insurance-linked products and disease-focused care offerings.
$5.41
-$0.02 (-0.37%)
Price from 2 days ago
14.40% operating margin is respectable but not wide. ROIC at 6.50%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue declined 0.0% YoY. Margins deteriorated 2.6pp alongside, both lines moving the wrong way.
At 85x earnings, the current multiple leaves limited room for execution misses or growth deceleration. ROIC dropped from 9.08% to 6.50%, capital efficiency is deteriorating.
84.5x earnings, 1.9x FCF. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
PEN 4.66B
Net Income (TTM)
PEN 31M
▼ -10.5% YoY
Op. Margin
13.23%
▼ -2.6pp YoY
ROIC
6.50%
▼ -2.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
PEN 725M
▼ -1.7% YoY
Op. Cash Flow (TTM)
PEN 852M
▲ +14.8% YoY
Net Debt
PEN 3.29B
Cash & Equiv.
PEN 366M
3Y CAGR: +21.4%
3Y CAGR: +264.7%
Continue Research
Is Auna (AUNA) overvalued?
At a P/E of 84.5 and a price-to-free-cash-flow of 1.9, Auna (AUNA) trades below a two-stage DCF intrinsic value of about PEN 452.78 per share, so at PEN 5.41 the stock looks undervalued (8,269.3% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Auna scores 64/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
What is Auna's fair value?+
Intrinsiqq's two-stage DCF estimates an intrinsic value of about PEN 452.78 per share for AUNA, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around PEN 339.58. At today's PEN 5.41, that puts the stock about 8,269.3% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Is Auna a high-quality business?+
Auna scores 64 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 13.2% operating margin and a 6.5% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Auna a good stock to buy right now?+
That depends on valuation and quality together, not either alone. AUNA currently trades below its estimated intrinsic value and scores 64/100 on quality (solid). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.
Related stocks: Medical Care Facilities
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing AUNA
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.